Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair O'Brien

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
BMJ Open Gastroenterology|November 30, 2022
Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver diseaseAlastair O'Brien
Hepatobiliary Surgery and Nutrition|December 16, 2022
In search of a roadmap towards improving care of patients with cirrhosis and ascites, could a platform trial design transform clinical research?Alastair O'Brien
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 18, 2018
Con: The Unclear Benefit of AlbuminAlastair O'Brien
Journal of Clinical and Experimental Hepatology|August 19, 2024
Changing the Dial on Pathogen Detection in SBPAlastair O'Brien
Gut|May 20, 2016
Is human albumin solution really the best resuscitation fluid for patients with advanced cirrhosis?Alastair O'Brien, Louise China,
Hepatology Communications|September 1, 2023
Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?Dominic Crocombe, Alastair O'Brien
Gastroenterology|May 13, 2008
Nutrition in end-stage liver disease: principles and practiceAlastair O'Brien, Roger Williams
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Antimicrobial resistance in liver disease: better diagnostics are neededLaura Shallcross, Alastair O'Brien
Hepatology (Baltimore, Md.)|September 30, 2008
Rapid diagnosis of Wilson disease in acute liver failure: no more waiting for the ceruloplasmin level?Alastair O'Brien, Roger Williams
Hepatology Communications|November 23, 2023
Reply: Antibiotic prophylaxis in palliative patients with cirrhosis: Stewardship or gatekeeping?Alastair O'Brien, Dominic Crocombe
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
BMJ Open Gastroenterology|November 30, 2022
Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver diseaseAlastair O'Brien
Hepatobiliary Surgery and Nutrition|December 16, 2022
In search of a roadmap towards improving care of patients with cirrhosis and ascites, could a platform trial design transform clinical research?Alastair O'Brien
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 18, 2018
Con: The Unclear Benefit of AlbuminAlastair O'Brien
Journal of Clinical and Experimental Hepatology|August 19, 2024
Changing the Dial on Pathogen Detection in SBPAlastair O'Brien
Gut|May 20, 2016
Is human albumin solution really the best resuscitation fluid for patients with advanced cirrhosis?Alastair O'Brien, Louise China,
Hepatology Communications|September 1, 2023
Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?Dominic Crocombe, Alastair O'Brien
Gastroenterology|May 13, 2008
Nutrition in end-stage liver disease: principles and practiceAlastair O'Brien, Roger Williams
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Antimicrobial resistance in liver disease: better diagnostics are neededLaura Shallcross, Alastair O'Brien
Hepatology (Baltimore, Md.)|September 30, 2008
Rapid diagnosis of Wilson disease in acute liver failure: no more waiting for the ceruloplasmin level?Alastair O'Brien, Roger Williams
Hepatology Communications|November 23, 2023
Reply: Antibiotic prophylaxis in palliative patients with cirrhosis: Stewardship or gatekeeping?Alastair O'Brien, Dominic Crocombe
Pageof 6